New anti-obesity drugs are game-changing but we need to tackle the root cause
Semaglutide, the drug from the Danish pharmaceutical big Novo Nordisk, was permitted below the model ‘Ozempic’ for the remedy of diabetes in 2017, adopted by Wegovy, the weight problems model ...